Merck & Co. stock pre-market at EUR 126.19: plus 0.39 percent
Published on 10/07/2026 at 07:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Merck & Co. stock traded pre-market at EUR 126.19 at 7:43 a.m. CEST on October 7, 2026, according to Lang & Schwarz. The price was up 0.39 percent versus the Lang & Schwarz prior close of EUR 125.70 on October 6, 2026.
Pre-market trading
Lang & Schwarz showed a bid of EUR 125.78 and an ask of EUR 126.60. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Merck & Co. stock.
Next earnings update
Merck & Co. said on October 1, 2026, that it will hold its third-quarter 2026 sales and earnings conference call on October 29 at 9:00 a.m. Eastern Time. Company executives are scheduled to provide an overview of the quarter’s performance.
Regulatory development
In a separate announcement dated September 18, 2026, Merck said the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion recommending approval of KEYTRUDA plus Padcev as perioperative treatment for adults with resectable muscle-invasive bladder cancer. The recommendation will be reviewed by the European Commission.
Merck’s release said the opinion was based on Phase 3 KEYNOTE-B15 results, which showed improvements in event-free survival, overall survival and pathologic complete response.
